FDA Proposal Classifies Skin Bleaching Products As Drugs

FDA is proposing a rule that classifies all over-the-counter skin bleaching products as drugs requiring an approved new drug application, the agency announced in a notice of proposed rulemaking published in an Aug. 29 Federal Register 1notice

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Archive

More from HBW Insight